Merck & Co., Inc. (LON:0QAH)
London flag London · Delayed Price · Currency is GBP · Price in USD
82.08
+2.00 (2.50%)
At close: Aug 13, 2025

Merck & Co. Revenue

Merck & Co. had revenue of $15.81B USD in the quarter ending June 30, 2025, a decrease of -1.90%. This brings the company's revenue in the last twelve months to $63.62B, up 1.82% year-over-year. In the year 2024, Merck & Co. had annual revenue of $64.17B with 6.74% growth.

Revenue (ttm)
$63.62B
Revenue Growth
+1.82%
P/S Ratio
3.28
Revenue / Employee
$848.21K
Employees
75,000
Market Cap
152.25B GBP

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202464.17B4.05B6.74%
Dec 31, 202360.12B832.00M1.40%
Dec 31, 202259.28B10.58B21.72%
Dec 31, 202148.70B7.19B17.31%
Dec 31, 202041.52B2.40B6.13%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AstraZeneca 41.24B
GSK plc 31.63B
Haleon 11.02B
Smith & Nephew 4.33B
ConvaTec Group 1.72B
Hikma Pharmaceuticals 2.35B
Oxford Nanopore Technologies 183.19M
HUTCHMED (China) 439.54M
Revenue Rankings